安康如果怀孕了不想要怎么办安康不会怀孕,安康怀孕一般多久不能同房,安康产后阴道出血怎么回事,安康经后咖啡色分泌物,安康阴唇长痘,安康月经来了可能怀孕吗,安康来月经了吃什么好

BEIJING, Aug 4 (Xinhuanet) – A new urine test might help doctors detect prostate cancer and better evaluate a patient's treatment options, according to American reseachers Thursday."This is a tool that men and their physician can use to help them decide whether it's appropriate to get a biopsy now or delay that decision," said lead researcher Dr. Scott Tomlins, a pathology resident at the University of Michigan Health System.The test looks for two genetic markers associated with prostate cancer. The first, called TMPRSS2:ERG, is caused by two genes changing places and fusing together; it is thought to cause prostate cancer. Since the gene fusion is only seen in about half of cancer patients, the test also looks for another marker, called PCA3."We are exploiting some new bio-markers to try to refine the PSA (prostate-specific antigen) test," Tomlins said.

SYDNEY, July 15 (Xinhua) -- The world's first drug to increase life expectancy of people with advanced melanoma has been approved for use in Australia, local media reported on Friday.The breakthrough drug Yervoy got approval from the Therapeutics Good Association (TGA) on Friday amid hopes it could add two years to the life of people with the most lethal form of skin cancer but for whom other treatments have failed, the Australian Associated Press (AAP) said.Clearance for the drug's use in Australia follows similar approvals by the U.S. health regulator in March.Yervoy works by attacking and destroying cancer cells.Patients are hooked up to an intravenous drip once every three weeks for a total of four doses.Professor Peter Hersey, consultant immunologist to the Melanoma Institute Australia, said no other drug had improved survival rates like Yervoy."Not all patients respond to it but those who do have a good chance of living longer than they would have otherwise," Hersey told AAP.While it may improve survival rates, Yervoy can produce side effects from diarrhea and vomiting to serious blood infections and kidney failure.The average survival time for people with advanced melanoma is just six months.A global study of 676 people with melanoma found that 45 percent of patients given Yervoy were still alive after one year, according to AAP.More than 20 percent lived at least two years, with a small number managing to survive for six years.A separate study, published in June, which showed similarly improved survival rates for patients with newly diagnosed advanced melanoma, has raised hopes that Yervoy could be made more widely available.Melanoma is the fourth most common cancer in Australia, with 10, 300 people diagnosed each year.

YANGON, July 10 (Xinhua) -- Myanmar is projecting to build the first-ever liver transplant hospital in line with the international standard, the local weekly Voice reported Sunday.With the technological help of the Changi General Hospital of Singapore, a 40-million-U.S dollar worth private hospital has started building since late last month.The hospital will offer services for the patients living with heart and kidney diseases and for protection from being affected Methicillin-Resistant Staphylococcus Aureus (MRSA), the report said.In Myanmar, liver transplant will cost about 20 million Kyats ( 25,000 U.S. dollars), lesser than other countries, the report added.Myanmar experts carried out successful liver-transplant operation in 2004 for the first time and in 2009 for the second time.

WASHINGTON, June 2 (Xinhua) -- When humans see red, their reactions become both faster and more forceful, according to a new study published this week in the U.S. bimonthly journal Emotion.The findings may have applications for sporting and other activities in which a brief burst of strength and speed is needed, such as weightlifting. But the authors caution that the color energy boost is likely short-lived.The study measured the reactions of students in two experiments. In the first, 30 fourth-through-10th graders pinched and held open a metal clasp. Right before doing so, they read aloud their participant number written in either red or gray crayon. In the second experiment, 46 undergraduates squeezed a handgrip with their dominant hand as hard as possible when they read the word "squeeze" on a computer monitor. The word appeared on a red, blue, or gray background.In both scenarios, red significantly increased the force exerted, with participants in the red condition squeezing with greater maximum force than those in the gray or blue conditions. In the handgrip experiment, not only the amount of force, but also the immediacy of the reaction increased when red was present.The colors in the study were precisely equated in hue, brightness, and chroma (intensity) to insure that reactions were not attributable to these other qualities of color."Red enhances our physical reactions because it is seen as a danger cue," explains coauthor Andrew Elliot, professor of psychology at the University of Rochester and a lead researcher in the field of color psychology. "Humans flush when they are angry or preparing for attack," he explains. "People are acutely aware of such reddening in others and it's implications."But threat is a double-edged sword, argue Elliot and coauthor Henk Aarts, professor of psychology at Utrecht University, in the Netherlands. Along with mobilizing extra energy, "threat also evokes worry, task distraction, and self-preoccupation, all of which have been shown to tax mental resources," they write in the paper.In earlier color research, exposure to red has proven counterproductive for skilled motor and mental tasks: athletes competing against an opponent wearing red are more likely to lose and students exposed to red before a test perform worse.